Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1846982rdf:typepubmed:Citationlld:pubmed
pubmed-article:1846982lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:1846982lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:1846982lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:1846982lifeskim:mentionsumls-concept:C0007121lld:lifeskim
pubmed-article:1846982lifeskim:mentionsumls-concept:C1561451lld:lifeskim
pubmed-article:1846982lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:1846982lifeskim:mentionsumls-concept:C0205187lld:lifeskim
pubmed-article:1846982pubmed:issue1lld:pubmed
pubmed-article:1846982pubmed:dateCreated1991-3-8lld:pubmed
pubmed-article:1846982pubmed:abstractTextThe five years survival rates of patients with non-operable non-small cell lung carcinoma are between 6% and 9%. Multiple attempts have been made to improve the response rate and the survival of these patients with different chemo- and radiotherapy schemes. The systemic chemotherapy with cisplatin-vindesine is until now one of the most active treatments with a response rate of 40%, but it is limited because of its side effects and toxicity. Eleven patients are treated one to four times with an intraarterial infusion of 3 mg/m2 vindesine and 20 mg/m2 cisplatin into the tumor-feeding bronchial artery combined with a simultaneous radiotherapy (60 Gy). Until now no major side effects occurred and the systemic toxicity was insignificant. An objective tumor response was encountered in 7/11 patients. The intraarterial chemotherapy combined with radiotherapy is strictly local and therefore effective especially in patients with limited or locally advanced disease.lld:pubmed
pubmed-article:1846982pubmed:languagegerlld:pubmed
pubmed-article:1846982pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846982pubmed:citationSubsetIMlld:pubmed
pubmed-article:1846982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846982pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1846982pubmed:statusMEDLINElld:pubmed
pubmed-article:1846982pubmed:monthJanlld:pubmed
pubmed-article:1846982pubmed:issn0179-7158lld:pubmed
pubmed-article:1846982pubmed:authorpubmed-author:KauffmannGGlld:pubmed
pubmed-article:1846982pubmed:authorpubmed-author:WannenmacherM...lld:pubmed
pubmed-article:1846982pubmed:authorpubmed-author:DringsPPlld:pubmed
pubmed-article:1846982pubmed:authorpubmed-author:BrambsH JHJlld:pubmed
pubmed-article:1846982pubmed:authorpubmed-author:RieberAAlld:pubmed
pubmed-article:1846982pubmed:issnTypePrintlld:pubmed
pubmed-article:1846982pubmed:volume167lld:pubmed
pubmed-article:1846982pubmed:ownerNLMlld:pubmed
pubmed-article:1846982pubmed:authorsCompleteYlld:pubmed
pubmed-article:1846982pubmed:pagination14-8lld:pubmed
pubmed-article:1846982pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:meshHeadingpubmed-meshheading:1846982-...lld:pubmed
pubmed-article:1846982pubmed:year1991lld:pubmed
pubmed-article:1846982pubmed:articleTitle[Combined intra-arterial chemotherapy and radiotherapy in inoperable non-small cell bronchial carcinoma].lld:pubmed
pubmed-article:1846982pubmed:affiliationAbteilung Radiodiagnostik, Universität Heidelberg.lld:pubmed
pubmed-article:1846982pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1846982pubmed:publicationTypeEnglish Abstractlld:pubmed